IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma
Condition(s):Multiple MyelomaLast Updated:November 4, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:November 4, 2015Completed
Condition(s):Multiple Myeloma in Relapse; Refractory Multiple MyelomaLast Updated:April 21, 2023Recruiting
Condition(s):HealthyLast Updated:November 12, 2019Completed
Condition(s):Recurrent Waldenstrom Macroglobulinemia; Refractory Waldenstrom MacroglobulinemiaLast Updated:October 5, 2023Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:October 20, 2022Completed
Condition(s):Multiple MyelomaLast Updated:October 24, 2018Completed
Condition(s):Multiple MyelomaLast Updated:November 1, 2016Completed
Condition(s):Multiple MyelomaLast Updated:August 23, 2021Withdrawn
Condition(s):Graft vs Host DiseaseLast Updated:February 25, 2016Completed
Condition(s):Multiple MyelomaLast Updated:July 27, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.